These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37051007)

  • 41. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
    Babaliche P; Nadpara RA; Maldar A
    J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microalbuminuria and Traditional Serum Biomarkers of Nephropathy among Diabetic Patients at Mbarara Regional Referral Hospital in South Western Uganda.
    Kiconco R; Rugera SP; Kiwanuka GN
    J Diabetes Res; 2019; 2019():3534260. PubMed ID: 31934589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
    Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
    Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
    Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
    Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.
    Deng X; Zhao L; Guo C; Yang L; Wang D; Li Y; Xia H; Wang C; Cai Z; Li L; Zhao Z; Yuan G
    Diabetes Metab Syndr Obes; 2020; 13():4341-4351. PubMed ID: 33223841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
    Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
    Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.
    Chang YH; Lin KD; Wang CL; Hsieh MC; Hsiao PJ; Shin SJ
    Diabetes Metab Res Rev; 2008; 24(8):629-34. PubMed ID: 18973209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.
    Petrica L; Petrica M; Vlad A; Dragos Jianu C; Gluhovschi G; Ianculescu C; Dumitrascu V; Giju S; Gluhovschi C; Bob F; Ursoniu S; Gadalean F; Velciov S; Bozdog G; Marian R
    Wien Klin Wochenschr; 2009; 121(23-24):765-75. PubMed ID: 20047115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Galectin-3 as a prognostic biomarker for diabetic nephropathy.
    Hodeib H; Hagras MM; Abdelhai D; Watany MM; Selim A; Tawfik MA; Elsebaey MA; Elshweikh SA
    Diabetes Metab Syndr Obes; 2019; 12():325-331. PubMed ID: 30936732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.
    Yun KJ; Kim HJ; Kim MK; Kwon HS; Baek KH; Roh YJ; Song KH
    Diabetes Metab J; 2016 Dec; 40(6):473-481. PubMed ID: 27766790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus.
    Metwalley KA; Farghaly HS; Gabri MF; Abdel-Aziz SM; Ismail AM; Raafat DM; Elnakeeb IF
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):293-299. PubMed ID: 33565751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study.
    Sánchez-Hidalgo JJ; Suárez-Cuenca JA; Lozano-Nuevo JJ; García-López VH; Leal-Gutiérrez MG; León-Angel SA; Ramírez-Villa ML; Rodea-Rubio ME; González-Hernández JE; Canela-Mayoral JA; Murillo-Heredia E; Vera-Gómez E; Hernández-Patricio A; Zamora-Alemán CR; Domínguez-Pérez GA; Gutiérrez-Buendia JA; Mondragón-Terán P
    Diabetol Metab Syndr; 2021 Nov; 13(1):128. PubMed ID: 34743740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.